Evidence map›Paper›PMID 31084341›Full record

Trial reportStroke2019

Temporal Trends in Ischemic Stroke Incidence in Younger Adults in the Framingham Study.

Hugo J Aparicio, Jayandra J Himali, Claudia L Satizabal, Matthew P Pase, Jose R Romero, Carlos S Kase, Alexa S Beiser, Sudha Seshadri

Open access · bronzeAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in Stroke, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 43 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Trends in Prevalence of Serious Psychological Distress and Depression Among Adults with Stroke in the United States.Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Hugo J AparicioFrom the Boston University School of Medicine, MA (H.J.A., J.J.H., C.L.S., J.R.R., C.S.K., A.S.B., S.S.).
Jayandra J HimaliFrom the Boston University School of Medicine, MA (H.J.A., J.J.H., C.L.S., J.R.R., C.S.K., A.S.B., S.S.).
Claudia L SatizabalFrom the Boston University School of Medicine, MA (H.J.A., J.J.H., C.L.S., J.R.R., C.S.K., A.S.B., S.S.).
Matthew P PaseThe Florey Institute for Neuroscience and Mental Health, Melbourne, Australia (M.P.P.).
Jose R RomeroFrom the Boston University School of Medicine, MA (H.J.A., J.J.H., C.L.S., J.R.R., C.S.K., A.S.B., S.S.).
Carlos S KaseFrom the Boston University School of Medicine, MA (H.J.A., J.J.H., C.L.S., J.R.R., C.S.K., A.S.B., S.S.).
Alexa S BeiserFrom the Boston University School of Medicine, MA (H.J.A., J.J.H., C.L.S., J.R.R., C.S.K., A.S.B., S.S.).
Sudha SeshadriFrom the Boston University School of Medicine, MA (H.J.A., J.J.H., C.L.S., J.R.R., C.S.K., A.S.B., S.S.).
Boston University · USThe University of Texas Health Science Center at San Antonio · USUniversity of Melbourne · AU

Funding

UC Davis Alzheimer's Disease Core CenterP30AG010129 · NIA · UNIVERSITY OF CALIFORNIA DAVIS · PI MEYER, OANH L · 1991 to 2020
$28.3M
South Texas Alzheimer's Disease Research CenterP30AG066546 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Mohamad Habes · 2021 to 2026
$24.0M
PRECURSORS OF STROKE INCIDENCE AND PROGNOSISR01NS017950 · NINDS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Hugo Javier Aparicio, Jose Rafael Romero · 1985 to 2026
$22.9M
Temporal Trends, Novel Imaging and Molecular Characterization of Preclinical and Clinical Alzheimer's Disease in the Framingham CohortsR01AG054076 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI DECARLI, CHARLES, SESHADRI, SUDHA · 2016 to 2020
$12.3M
Microglial, Inflammatory and Omics Markers of Cerebral Small Vessel Disease in the CHARGE ConsortiumUH3NS100605 · NINDS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI FORNAGE, MYRIAM, SESHADRI, SUDHA · 2018 to 2020
$3.0M
THE FRAMINGHAM HEART STUDY-N01HC25195-268025195-268025195N01HC025195 · HC · TRUSTEES OF BOSTON UNIVERSITY · PI WOLF, PHILIP A · 2002 to 2006
–
NHLBI NIH HHS HHSN268201500001CNHLBI NIH HHS HHSN268201500001INHLBI NIH HHS N01 HC025195NIA NIH HHS P30 AG010129NIA NIH HHS P30 AG066546NIA NIH HHS R01 AG054076NINDS NIH HHS L30 NS093634NINDS NIH HHS R01 NS017950NINDS NIH HHS UH3 NS100605
6 · The paper itself

Abstract

Background and Purpose- Stroke at midlife has a disproportionately large impact on disability-adjusted life-years lost. Ischemic stroke incidence may be increasing at this age. We investigated long-term trends in ischemic stroke incidence and changes in stroke risk factors in a community sample stratified by stroke onset at middle and older age. Methods- In the Framingham Study, surveillance for incident stroke is ongoing since 1948. We examined age-adjusted and sex-adjusted 10-year incidence of ischemic stroke using Cox models in persons aged 35 to 54 and ≥55 years at start of follow-up. Tests for linear trend were performed over 4 epochs, controlling for the distance in time between intervals. Further, we calculated the mean 10-year risk of stroke at each epoch and for both age groups, based on vascular risk factors from the Framingham Stroke Risk Profile. Results- There were 153, 197, 176, and 165 incident ischemic strokes within each epoch beginning in 1962 (n=3966), 1971 (n=5779), 1987 (n=5133), and 1998 (n=6964). Most ischemic strokes at midlife (n=71) were because of atherosclerotic brain infarction (n=50) or cardioembolism (n=19). Using the risk in the 1962 epoch as the reference, the risk of ischemic stroke at midlife did not significantly decline (hazard ratio, 0.87; 95% CI, 0.74-1.02; P trend =0.09). Incidence of ischemic stroke declined in the older group (hazard ratio, 0.82; 95% CI, 0.77-0.88; P trend <0.001). Between epochs 1 and 4, the average 10-year risk of stroke, as estimated by the Framingham Stroke Risk Profile, declined by 0.7% at midlife and 1.1% at older age. Conclusions- Long-term rates of ischemic stroke declined in our community sample; the decline was greater in older as compared with younger adults. Early prevention, focused on modification of cardiovascular risk factors, is important to see sustained declines in stroke incidence and mortality at midlife.

Indexed as

AdultBrain InfarctionFemaleFollow-Up StudiesHumansIncidenceIntracranial ArteriosclerosisIntracranial EmbolismMaleMiddle AgedRisk FactorsStrokeTime FactorsYoung Adultatrial fibrillationbrain infarctioncerebrovascular disordersepidemiologyrisk factors

Identifiers

PMID31084341
PMCPMC6538454
OpenAlexW2945612666

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.